Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

Search Results

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

evt | Article | September 2007

AneuRx® Stent Graft Clinical Update Vol. IV

Frank Arko, MD; Ali Azizzadeh, MD, FACS; and Rodney White, MD, discuss the AneuRx 5-year data, how they compare to their own experiences, and the future implications for physicians.

By Frank Arko, MD; Ali Azizzadeh, MD, FACS; and Rodney White, MD

evt | Article | March 2019

EVAR—What Does the Future Hold?

By Ali Azizzadeh, MD, FACS; and Dittmar Böckler, MD, PhD

evt | Article | August 2017

Acute Type A Aortic Dissection

Moderator: Ali Azizzadeh, MD, FACS
Panel: Benjamin Jackson, MD, FACS; Joseph Bavaria, MD, FACS; Kristofer M. Charlton-Ouw, MD, FACS; Anthony L. Estrera, MD, FACS; Michael Fischbein, MD, PhD; Michael D. Dake, MD; and Jason T. Lee, MD

Sponsored by Gore & Associates

evt | Article | March 2015 Supplement

Unmet Needs With Current Thoracic Devices

Significant opportunities remain for research and development.

By Ali Azizzadeh, MD, FACS

Advertisement

Sponsored by Gore & Associates

evt | Article | February 2012 Supplement

Management of Blunt Traumatic Aortic Injury

How to best utilize TEVAR to treat this challenging presentation.

By Ali Azizzadeh, MD, FACS

Sponsored by Medtronic

evt | Article | March 2016

Evolving Treatments for Aortic Dissection

A review of classifications and endovascular repair for this challenging clinical presentation.

By Babafemi B. Pratt, MD, and Ali Azizzadeh, MD

evt | Article | November 2018

Ask the Experts: Aortoenteric/Aortobronchial Fistulas: Is TEVAR Acceptable?

Experts share their strategies for first-line treatment in these very challenging and often morbid presentations.

With Ali Azizzadeh, MD, FACS; Timur P. Sarac, MD; Venita Chandra, MD; and Raghuveer Vallabhaneni, MD, FACS

evt | Article | February 2013

Managing Type II Endoleaks

Although a common complication, type II endoleaks are not always benign and require innovative treatment strategies.

By Naveed U. Saqib, MD; Kristofer M. Charlton-Ouw, MD; and Ali Azizzadeh, MD, FACS

Sponsored by Gore & Associates

evt | Article | March 2018 Supplement

Optimizing TEVAR Outcomes in Acute and Subacute Type B Aortic Dissections

Procedural planning and intraoperative techniques to increase the likelihood of success.

By Bruce Tjaden, MD, and Ali Azizzadeh, MD, FACS

evt | Article | November 2014

Why an Optimal BTAI Grading System Is Needed

Creating and implementing a grading system that can direct practice algorithms for blunt thoracic aortic injury treatment.

By Joseph DuBose, MD, FACS, FCCM, and Ali Azizzadeh, MD, FACS

evt | Article | January 2023

Essential Elements of a Comprehensive Aortic Team

Experts share their experience and advice for creating top-flight aortic teams, training juniors, being prepared for aortic emergencies, and ensuring safety for patients and operators.

With Ali Azizzadeh, MD, FACS; Kendal Endicott, MD; Javairiah Fatima, MD, FACS, RPVI, DFSVS; Ross Milner, MD, FACS; and Brant W. Ullery, MD, MBA, FACS, FSVS

evt | Article | November 2016

Ask the Experts: If a Complicated Type B Dissection Presents With Proximal Extension to the LCCA, How Should It Be Managed?

With Ali Azizzadeh, MD; Eric E. Roselli, MD; Matthew Thompson, MD, FRCS; and Dittmar Böckler, MD, PhD, MHBA

evt | Article | November 2019

Ask the Experts: Acute TBAD: What Is Your Strategy Regarding Extent of Coverage and Use of Covered Versus Bare Stents?

Expert insight on treatment options for TBAD via TEVAR.

With Ali Azizzadeh, MD, FACS; Ian M. Loftus, MD, FRCS; Audra A. Duncan, MD, FACS, FRCSC; Joseph Lombardi, MD; and Germano Melissano, MD

evt | News | November 1, 2015

Two-Year Data Presented for Medtronic's Valiant Captivia TEVAR Device in Acute Type B Aortic Dissection

November 2, 2015—Ali Azizzadeh, MD, reported 2-year results of thoracic endovascular aortic repair with the Valiant Captivia thoracic stent graft (Medtronic) in patients with acute type B aortic dissection complicated by malperfusion or contained rupture that carried a high risk of mortality.

evt | News | November 5, 2014

DISSECTION Data Are Encouraging for Medtronic's Valiant Captivia for Treatment of Type B Dissection

November 5, 2014—VIVA Physicians, Inc. announced that Ali Azizzadeh, MD, presented findings from the United States investigational device exemption DISSECTION trial of Medtronic, Inc.’s Valiant Captivia thoracic stent graft during the late-breaking trials session at the VIVA 2014: Vascular InterVentional Advances meeting in Las Vegas, Nevada.

evt | News | September 19, 2016

DISSECTION Evaluates Medtronic's Valiant Captivia Thoracic Stent Graft at 3 Years in Complicated Type B Aortic Dissections

September 20, 2016—Ali Azizzadeh, MD, presented findings from the Medtronic DISSECTION trial during the second Late-Breaking Trials session at VIVA 16, the 14th annual Vascular InterVentional Advances meeting, which was sponsored by VIVA Physicians, Inc. and held September 18–22, 2016 at the Wynn Las Vegas in Las Vegas, Nevada.

evt | News | September 19, 2016

Three-Year Data Presented for Medtronic's Valiant Captivia to Treat Acute Complicated Type B Aortic Dissections

September 20, 2016—Medtronic plc announced new data demonstrating safety and efficacy at 3 years in patients with acute complicated type B aortic dissection treated with the Valiant Captivia thoracic stent graft system.

evt | News | March 24, 2026

SVS Updates Guidelines for Blunt Thoracic Aortic Injury

March 24, 2026—The Society for Vascular Surgery (SVS) announced the release of an updated clinical practice guideline on the management of blunt thoracic aortic injury (BTAI).

evt | News | November 21, 2019

Medtronic Presents 1-Year Valiant Navion and 4-Year ANCHOR Registry Outcomes

November 22, 2019—Medtronic announced the presentation of 1-year outcomes for the Valiant Navion thoracic stent graft system for thoracic endovascular repair (TEVAR) and 4-year clinical outcomes from the ANCHOR registry evaluating the company’s Heli-FX EndoAnchor system in patients with hostile neck abdominal aortic aneurysms (AAAs) at the VEITHsymposium held November 19–23 in New York, New York.

evt | News | June 7, 2016

Clinical Trial Begins for Medtronic's Next-Generation Valiant Evo TEVAR Device

June 8, 2016—Medtronic plc and the University of Texas Health Science Center at Houston (UTHealth) in Houston, Texas announced the enrollment of the first patient in a clinical study assessing the Valiant Evo thoracic stent graft system for the minimally invasive repair of descending thoracic aortic aneurysms (TAA).

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button